Jamie Beachy MDiv, PhD

Jamie Beachy, MDiv, PhD, is a spiritual health educator, ethics consultant, and psychedelic therapy practitioner. She was a sub-investigator for MAPS Phase 3 clinical trials in Boulder, Colorado, researching the safety and efficacy of MDMA-assisted therapy for the treatment of PTSD. Dr. Beachy now serves as a consultant/supervisor, offering consultation for practitioners training in MDMA-Assisted therapy. 

Dr. Beachy developed graduate level course offerings and curricula related to psychedelic therapies as Director of Education and Faculty Co-founder of Naropa University’s Center for Psychedelic Studies. An advocate for the integration of spiritual health and psychedelic care, she co-founded the Psychedelic Care Research Network through the Transforming Chaplaincy initiative and has spoken broadly on the role of professional spiritual care in psychedelic therapy. Additionally, she serves as the Chair of the Board of Directors of the Chacruna Institute for Psychedelic Plant Medicines.

Certified in CBCT® (Cognitively-Based Compassion Training), a program developed at the Center for Contemplative Science and Compassion-Based Ethics at Emory University, Dr. Beachy seeks to integrate insights from contemplative practice into emerging psychedelic therapy best practices.

Academics

• BA, Colorado State University
• MDiv, Pacific School of Religion
• PhD, University of Denver/Iliff School of Theology

Featured Articles

• Top ten tips palliative care clinicians should know about psychedelic-assisted therapy in the context of serious illness. Journal of palliative medicine, 2022.
• An Expert Informed Introduction to the Elements of Psychedelic-Assisted Therapy, Brainfutures, 2022.
• Chaplaincy and Psychedelic-Assisted Therapy: Opportunities and Barriers, Reflective Practice, 2022.
• Tending the Sacred: The Emerging Role of Chaplaincy and Psychedelic Therapies - MAPS Bulletin, 2021.

Meet Jamie Beachy

What is Psychedelic Chaplaincy